Evexia Lifecare's Vadodara API facility to start operations from April 18, 2022

Evexia Lifecare Limited had earlier announced regarding setup of Active Pharmaceutical Ingredient (API) / Intermediate manufacturing plant of Isometamidium (Isometa). The company has completed all the formalities in respect of Government Licenses. Now, the company has planned to start its manufacturing facility from 18th April 2022 onwards at Vadodara based plant.

The company has also decided to build up more than 150000sqft plant facility at Vadodara based location. This facility will be in accordance with the USFDA for the manufacturing of the other APIs and Intermediate products.

The company is expecting significant achievement in respect of production and market share of these products. Company's scientists are working 24*7 for trials of other APIs/intermediates at a world class facility of laboratory available at the Vadodara based location.

Source : Equity Bulls

Keywords

EvexiaLifecare API Isometamidium ManufacturingFacility Vadodara